Usage, warnings, side effects, and community information for the prescription drug Gabapentin A US-based subsidiary of Sun Pharma is recalling around 13,700 bottles of Gabapentin capsules, a medication used to treat and prevent seizures in people with epilepsy. Several generic drugs were recalled over quality concerns; check lot numbers and talk to your pharmacist if your medication is affected. This recall is due to a potential mix-up of Metformin ER Tablets in a bottle of Gabapentin Tablets, USP 600mg. The ongoing investigation revealed that the issue is limited to the above lot and no other lots were impacted. Description: Gabapentin Tablets 600mg, 500-count bottles, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India, Manufactured for: Glenmark Pharmaceuticals Inc. USA, Mahwah, NJ 07430. Which Drugs Were Recalled? There were 39 different generic medications included in this recall, used to treat dozens of different conditions. The most recent Recall Enforcement Report that covers this product was initiated on July 31st, 2024 and classified as a Class II recall due to presence of foreign tablets; 3 fused tablets of metformin er 500 mg were found in bottle of gabapentin tablets This recall is currently completed, and the associated recall number is recall number is D-0634-2024. It pertains to Gabapentin identified by Drug Recall Enforcement Report Class II voluntary initiated by Granules Pharmaceuticals Inc., initiated on 07-31-2024 for the product Gabapentin Tablets, USP, Drug Recall Enforcement Report Class III voluntary initiated by Sciegen Pharmaceuticals Inc, originally initiated on 02-17-2023 for the product Gabapentin Tablets, USP 600 mg, 500 tablets per bottle, RX Only, Manufactured by ScieGen Pharmaceuticals Inc., Hauppauge, NY 11788, NDC: 50228-177-05. The product was recalled due to presence of foreign tablets/capsules: pharmacist reported presence of A recall has been issued for almost 4000 cartons of gabapentin tablets distributed throughout the United States due to contamination. When a medication you depend on gets pulled from shelves, knowing what to do next can be the difference between staying safe and facing serious health risks. The FDA oversees a complex system for removing dangerous drugs from the market, but navigating this system requires understanding how it works. This guide explains what drug recalls The recall affects 13 728 bottles—12 876 bottles of 300 mg capsules and 852 bottles of 400 mg capsules—due to concerns of cross contamination during manufacturing. The impacted lots, with expiration dates ranging from March to August 2025, were distributed nationwide across the United States. A US-based subsidiary of Sun Pharma is recalling around 13,700 bottles of Gabapentin capsules, a medication used to treat and prevent seizures in people with epilepsy. FDA warns about serious breathing problems with seizure and nerve pain medicines gabapentin (Neurontin, Gralise, Horizant) and pregabalin (Lyrica, Lyrica CR) FDA Drug Safety Podcast The U.S. Food and Drug Administration (FDA) has reported that Aurobindo Pharma USA is voluntarily recalling Gabapentin 300 mg capsules from lot GESB14011-A in 100-count bottles. The product lot affected was found to include some empty capsules; thus, if taken by a person with seizures, they would The most recent Recall Enforcement Report that covers this product was initiated on July 31st, 2024 and classified as a Class II recall due to presence of foreign tablets; 3 fused tablets of metformin er 500 mg were found in bottle of gabapentin tablets This recall is currently terminated, and the associated recall number is recall number is D-0634-2024. It pertains to Gabapentin identified by The latest safety updates on drugs - including duloxetine recall, new warnings for gabapentin-type drugs, tetracycline new warnings, and more. Glenmark, Sun Pharma, and Zydus are recalling various products in the US due to manufacturing issues and CGMP deviations, according to the USFDA. Glenmark is recalling over 25 products, while Sun Pharma is recalling Gabapentin capsules due to cross-contamination. Zydus is recalling chlorproMAZINE Hydrochloride Tablets due to an impurity exceeding the recommended limit. PetMD goes on to note that gabapentin may also be used in the veterinary setting for some animals experiencing pain, seizure, or anxiety. The specific reason for the recall is cited as cross-contamination, but it’s not clear whether that means individual tablets were contaminated, or whether perhaps another drug reached the packaging.
Articles and news, personal stories, interviews with experts.
Photos from events, contest for the best costume, videos from master classes.
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |
![]() | ![]() |